Article

jdsupra.com on 2024-05-11 00:24

US FTC Continues Aggressive Scrutiny of Pharmaceutical Patents Listed in the Orange Book

On April 30, 2024, the US Federal Trade Commission (“FTC”) announced that it had sent “warning letters” to 10 branded pharmaceutical manufacturers, ...

New York

Amneal Pharms

Related news

FTC Ratchets up Scrutiny on Pharmaceutical Deals jdsupra.com
California , United States , Switzerland
D.C. Circuit Affirms: FTC Can Change HSR Rules Targeted at Pharmaceutical Patents jdsupra.com
FTC Challenges More Than 100 Patents as Improperly Listed in Orange Book jdsupra.com
FTC Employs New Tactic in Effort Against Drug Makers Alleged to Have Improperly Listed Patents in the FDA’s Orange Book jdsupra.com
Sherman , Tactic
The March on Pharmaceutical Patents?jdsupra.com
Pete Buttigieg proposes seizing patents and steep taxes on pharmaceutical companies who won't negotiate drug prices CNN
United States , South Carolina , Vermont , California , Washington
Amazon cloud unit draws antitrust scrutiny from FTC ocregister.com
New York
UPSTO Continues Discussion of Pharmaceutical Patents jdsupra.com
FTC Proposes Increased Merger Scrutiny jdsupra.com
Biden commits to waiving vaccine patents, irking pharmaceutical companies The Day
North Carolina , Russia , China , South Africa , Canton of Geneva
Paid celebrity posts attract FTC scrutiny triblive.com
Sunglass Hut , New York
Three Changes to Pharmaceutical Patents in the PRC jdsupra.com
China , United States , Taiwan
Baby Formula Shortage Subject of FTC Scrutiny jdsupra.com
Apple Music faces scrutiny from the FTC engadget
FTC Increases Scrutiny of Negative Option Marketing jdsupra.com
"Improper” Listing of Patents in the FDA’s Orange Book jdsupra.com
New York , Sherman , New Jersey , Delaware , Massachusetts
Orange Book-Listed Patents Challenged in AIA Trial Proceedings jdsupra.com
FTC Competition Director Highlights Enforcement Priorities in the Pharmaceutical Industry jdsupra.com
FTC to the Rescue Regarding High Drug Prices and Patents jdsupra.com
California , United States , Switzerland
India, China Pharmaceutical Companies Face Increasing Scrutiny In Washington Forbes
San Francisco , Wuhan , China , Washington , India